Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What CAGR And Valuation Are Anticipated For The Dupuytren’s Disease Market?

There has been a robust growth in the market scale of dupuytren’s disease in the past few years. The market is projected to escalate from a worth of $4.28 billion in 2024 to $4.51 billion in 2025, boasting a compound annual growth rate (CAGR) of 5.3%. The surge seen during the historical period is due to a combination of factors including an aging population, heightened genetic vulnerability, growing occurrence of diabetes, an upsurge in alcohol consumption, and an increase in manual labor leading to repeated hand trauma.

The market for Dupuytren’s disease is projected to experience robust growth over the coming years, reaching $5.62 billion by 2029, reflecting a compound annual growth rate of 5.7%. This anticipated growth during the forecast period can be attributed to the improvement in treatment methods, increased awareness and early detection, escalated healthcare spending, the rising popularity of less invasive procedures, and an expansion of research and development activities. Notable trends to watch for in the forecast period include progress in gene therapy, advancements in regenerative and stem cell therapy, innovation in artificial intelligence-enhanced diagnostic tools, progression in 3D printing for tailor-made orthotics, and advancements in minimally invasive surgical procedures.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21944&type=smp

What Core Drivers Are Expected To Influence The Dupuytren’s Disease Market?

The growth of the Dupuytren’s disease market is anticipated to be driven by the increasing popularity of minimally invasive treatments. These medical procedures, characterized by their minimal incisions or tissue damage, offer benefits such as pain relief and reduced scarring. As these treatments offer a quicker recovery period with fewer discomforts and significantly less potential complications compared to conventional surgery, more individuals are opting for them. They effectively mitigate the effects of Dupuytren’s disease by improving hand function, diminishing contracture and facilitating a faster, more comfortable recovery process. In June 2023, for example, the Royal Australasian College of Surgeons (RACS), an Australia-based government organization, reported a 12% rise in procedures carried out with da Vinci platforms, escalating from 17,852 in 2021 to 19,989 in 2022 within Australia. As a result, the expansion of the Dupuytren’s disease market is being significantly influenced by this trend towards minimally invasive treatments.

What Are The Main Segment Classifications In The Dupuytren’s Disease Market?

The dupuytren’s diseasemarket covered in this report is segmented –

1) By Disease Type: Type I; Type II; Type III

2) By Treatment: Surgery; Radiation Therapy; Needle Aponeurotomy; Steroid Shot; Enzyme Injection; Occupational Therapy; Other Treatments

3) By Route of Administration: Oral; Parenteral; Other Routes Of Administration

4) By Diagnosis: Physical Examination; X-Ray; Other Diagnosis

5) By End-User: Hospitals; Clinics; Academic And Research Institute; Other End-Users

Subsegments:

1) By Type I: Classical Dupuytren’s Disease; Familial Dupuytren’s Disease

2) By Type II: Palmar Fasciitis; Ledderhose Disease

3) By Type III: Garrod’s Pads; Peyronie’s Disease

How Are Industry Trends Steering The Expansion Of The Dupuytren’s Disease Market?

In the Dupuytren’s disease market, companies are pursuing clinical trials to develop new first-line, disease-modifying treatments. Clinical trials assess the safety, efficacy, and side effects of novel therapies before approval. For example, in April 2023, Ventoux Biosciences, a US biopharmaceutical company specializing in non-surgical Dupuytren’s therapies, announced positive preclinical results for VEN-201, a fibrosis treatment targeting Dupuytren’s contracture, a condition affecting about 5% of the US population. VEN-201 is a repurposed commercially available drug that reduced skin fibrosis in mouse models, prompting Ventoux to launch a fundraising campaign to advance its development.

Which Companies Are Contributing Significantly To The Dupuytren’s Disease Market Growth?

Major companies operating in the dupuytren’s disease market are Pfizer Inc., Aetna Inc., Mayo clinic, Penn Medicine, Mercy Health, Endo Inc., Resilience Orthopedics, Raleigh Orthopaedic, Hoag Orthopedic Institute, OSS Health, Connext Inc., University of Utah Health, Ventoux Biosciences Inc., Auxilium Pharmaceuticals, 180 Life Sciences Corp., Brigid Freyne MD, Nantong Jinghua Pharmaceutical Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Actiza Pharmaceutical Private Limited, Spear Pharmaceuticals

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/dupuytrens-disease-global-market-report

Which Region Holds The Greatest Opportunity For Dupuytren’s Disease Market Expansion?

North America was the largest region in the dupuytren’s disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dupuytren’s disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=21944&type=smp

Browse Through More Reports Similar to the Global Dupuytren’s Disease Market 2025, By The Business Research Company

Respiratory Disease Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/respiratory-disease-drugs-global-market-report

Pharmaceutical Drugs And Biologics Logistics Market 2025

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-and-biologics-logistics-market

Autoimmune Disease Diagnosis Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model